INNOVATIVE RESEARCH OF AMERICA
`
`PH
`
`Most scientists agree that the three essential parameters in the success of a biomedical
`experiment are:
`
`A. The scientific problem formulated in a defined question.
`
`B. The laboratory animal, healthy and untraumatized.
`
`C. The process of active product delivery; the most problematic variable of all three!
`
`For a third of a century, Innovative Research of America has assumed the leadership role
`
`in improved time release technology. The main mission is t.o standardize the technology of
`
`drug delivery. Our proven Time Release Hormone and Drug Pellets help investigators take
`
`charge of product delivery and expand their abilities to do meaningful and reproducible
`
`research.
`
`ADVANTAGES OF THE PELLET DELIVERY SYSTEM
`
`i- a- ‘ready-to.'—a_dIr_ii.niste'r pellet foria-_s'i1_n_p_le_ subqgtafiejousi ’
`
`
`
`-:_-_a-hefizer--met.h:od toiaivioiid--the
`
`
`
`I
`
`Uslieiing In The Age Oflnnovative Research
`
`Astraleneca Ex. 2044 p. 2
`
`

`
`HORMONE AND DRUG PELLETS FOR BIOMEDICAL RESEARCH
`
`
`
`Since it is not easy to administer drugs and hormones orally to research animals.
`
`several delivery methods have been devised as alternatives. However, most scientists
`
`continue to labor with unreliable injectables to conduct their research.
`
`Because of this inadequacy. biomedical research is as confusing as it is challenging
`
`and as frustrating as it is creative. The options of scientists to address scientific questions
`
`are not only dependent, but are also limited by the process of active product delivery.
`
`Traditionally, product delivery into the experimental animal has been the procedure most
`
`subject to variables and the most difficult to standardize effectively. The very process
`
`of having to accurately administer drugs to experimental animals can become a logistic
`
`nightmare for scientists.
`
`CHANGING THE TIME COURSE OF DRUG DELIVERY
`
`We. Tell Ti111c—Relea-we Pellets W.l1at Time It is
`
`Astraleneca Ex. 2044 p. 3
`
`

`
`IRA TABLE OF CONTENTS
`
`Find a Product in this Catalog ........................................................ .. 5
`
`Ordering information I General Policy 8: Terms ............. .. 6, 7, 44, 84
`
`Sales of Anabolic Steroids ............................................................. .. 8
`
`Category Index.......................................................................... .. 10-15
`
`Alkaloids
`Amino Acids
`Androgens
`Antibiotics
`Anti-Inflammatory Agents
`Anti-Neoplastics
`Catecholamines
`Corticoids and Diuretics
`
`Estrogens
`Fatty Acids
`Nucleotide Related Products
`Progestins
`Prostaglandins
`Thyroids
`Vitamins
`
`Placebo Pellets lntorunertim I 4;’-3:r"i:::-e
`
`--_';
`
`Alphabetical Product Listing ................................................... .. 21-42
`
`Stock Pellet Price Schedules ................................................... .. 45-71
`
`Pellets for lmmuno-Deficient Mice
`
`17B-Estradiol [Tamoxifen & Sample References ................... .. 73-77
`
`Androgens I Anti-Androgens 8 Sample References ............. .. 78-80
`
`Trochar 8: Recommended Implantation Procedure ............. ..81, 123
`
`Doxycycline 8: Tetracycline Pellets in Mice ............................ .. 85-86
`
`Hormone + Hormone Pellets ................................................... .. 89-92
`
`Custom Pellets ........................................................................ .. 93-108
`
`Selected References ............................................................. ..109-122
`
`Order Forms ............................................................ .. Back of Catalo -
`
`Patents ................................................................. .. Inside Back Cover
`
`*Fm-further assisrance, view our website at:
`vmvw.r'nnovrsrch.com
`
`We Add Time To Your Day
`
`Astrazeneca Ex. 2044 p. 4
`
`

`
`PRODUCT DESIGN AND FEATURES
`
`
`
`The Pellet Implantation Methodology provides solutions to:
`
`consistency in timing repeated product administrations.
`
`controlling the amount of product administered.
`
`stability of the product preparation.
`
`safety of the experimenter.
`
`neurophysiological trauma to the animal from excessive handling.
`
`freeing valuable research time.
`
`eliminating unnecessary and unstimulating laboratory practices.
`
`Scientists from several research disciplines have documented in scientific literature that
`
`our Pellet Delivery System is effective, consistent, reproducible, economical, reliable, and
`
`safe for the animal. See Selected References on pages 109-122.
`
`Onl}-' Time Release Pellets Re:1ll_\_.-' Know What Time [1 15
`
`Astrazeneca Ex. 2044 p. 5
`
`

`
`PRODUCT SPECIFICATIONS
`
`AVAILABLE SHAPES AND SIZES
`
`Stock pellets are round and range in diameter from US” ('3 mm) to H2” (1.25 cm) depending on the
`dose and the release rate. Our Custom Pellets Department will also design various pellet shapes and
`smaller sizes (Page 94) to meet your research needs. Please refer to the Custom Pellets section on pages
`93-108.
`
`AVAILABLE DOSAGES
`
`Most of the stock products in this catalog are available in 20 different dosages ranging from 1 microgram
`(0.001 mg) per pellet up to 200 milligrams (200 mg) per pellet within the specified release rate. Doses of
`pellets listed in this catalog reflect the total amount of net active product released over the indicated
`period of time.
`
`AVAILABLE RELEASE RATES
`
`Stock products are designed to release continuously for 21 days, '60 days, or 90 days. Please refer to our
`Custom Pellets section on pages 93- 108 for other release rates tailored for the duration of the experiment.
`
`AVAILABLE PRODUCTS
`
`In our continuing quest to make available new stock items that are particularly in demand, we have added
`several products to the original categories. In addition to the listed pelletized products, Innovative
`Research of America has an efficient Custom Pellets Department to prepare products that are not available
`as stock items.
`
`SELECTED REFERENCES
`
`A sample of publications that employed our delivery system in a broad spectrum of products can be found
`on pages 109-122.
`
`Consistent Dose—Dependent Release
`
`Astrazeneca Ex. 2044 p. 6
`
`

`
`FINDING A PRODUCT IN THIS CATALOG
`
`
`
`The PRODUCTS in this catalog are arranged in ALPHABETICAL ORDER and are identified by
`a CATALOG NUMBER and 21 PRICE SCHEDULE with a PAGE NUMBER.
`
`The catalog number and price schedule reflect a release rate of 21 days, 60 days, or 90 days.
`
`To illustrate with 17B-Estradiol as an example:
`
`EXAMPLE
`
`Product
`
`21-Day Release
`Catalog
`Price Schedule!
`Number
`Page Number
`
`60-Day Release
`Catalog
`Price Schedule?
`Number
`Page Number
`
`90-Day Release
`Catalog
`Price Schedule!
`Number
`Page Number
`
`17B — Estradiol
`
`E - 121
`
`B-21f48
`
`
`
`SE - 121
`
`B-60f49
`
`NE - 121
`
`B-9050
`
`The above example indicates that l'Fl3-Estradiol is available in three release forms each having a
`
`different catalog number and price code, i.e.
`
`E - 121 is a 21-day release form with a price code of B-21, found on page 48.
`
`SE - 121 is a 60-day release form with a price code of B-60, found on page 49.
`
`NE - 121 is a 90-day release form with a price code of B-90, found on page 50.
`
`The PAGE NUMBER next to the PRICE SCHEDULE indicates the page where the actual price
`
`for the product appears.
`
`When ordering please use the PRODUCT NAME, CATALOG NUMBER, RELEASE
`
`RATE and DOSE. Most products are available in 20 different dosages. Products are sold in
`
`Lots of 25, 50, 100. and 200 pellets. Please indicate the quantity of pellets being ordered.
`
`Beginning on Page. 10 we have grouped some of our catalog items in related categories
`
`alphabetically. We hope the listing will help in noting items of potential interest.
`
`Time-Release Pellets... Alw.ays On Time.
`
`Astrazeneca Ex. 2044 p. 7
`
`

`
`
`
`° Mail
`
`0 Internet I E-Mail
`
`Innovative Research of America, Inc.
`
`http:r'!www-innovrsrch.com (website)
`
`2 North Tamjamj Trail
`
`pellets@innovrsrch.com (e-mail)
`
`Suite 404
`
`Sal-a50ta_ F]0rjda 34236 USA
`
`- Phone
`
`(941) 365-1406
`
`(941) 365-1506
`(300) 421-8171 (USA/Canada)
`
`0 Fax
`(941) 365-1703
`(941) 365-1803
`
`(800) 643-4345 (USA/Canada)
`
`(800) 648-6030 (USA/Canada)
`
`IRA’s website features our company profile,
`the latest product technology and on-line ordering.
`
`6 AMERICAN EXPRESS
`
`VISA AND MASTERCARD ACCEPTED.
`E Purchase Order Forms are in the back of the
`Wales.
`Custom Pellets Information Form on page 95
`
`'
`
`Bank Wire Payment Information
`Payment via bank wire should be directed as follows."
`
`lS
`THE DlT'FEK'ENCE
`CDNSISTENCY AND MNIFDRMHY.
`
`"'B“‘”“'""
`1800 Second SL, Suite I00
`Sarasota. Florida 34236
`
`Routing # (ABA) 26319138?
`Eleclronic Transfers # 263191337
`
`In favor of:
`Innovative Research of America
`
`Swift Code: BRBTUS33
`
`2 North Tamiami Trail
`Suite 404
`
`Sarasota, FL 34236
`
`Checking Account: #0000l478l6l54
`
`Llsliering In The Age Of lnnox--‘alive Researcli
`
`Astraleneca Ex. 2044 p. 8
`
`

`
`

`
`SALE OF CONTROLLED ANABOLIC STEROIDS
`
`within the United States
`
`
`(Telephone orders will not be accepted - orders & copy of DEA license may be mailed or faxed)
`
`Before we can prepare any orders of Anabolic Steroid Pellets, the Drug
`
`Enforcement Administration (DEA) requires us to obtain;
`
`1. A valid photocopy of the investigator’s DEA Registration
`
`containing Schedule 3N.
`
`2. A written Purchase Order showing the investigator’s DEA
`
`Registration Number and proper shipping address.
`
`CONTACT INNOVATIVE RESEARCH OF AMERICA
`
`BY PHONE. MAIL, FAX OR E-MAIL
`
`FOR MORE ORDERING INFORMATION - SEE PAGE 6
`
`SALE OF CONTROLLED ANABOLIC STEROIDS
`
`outside the United States (International)
`
`
`WE NO LONGER SHIP ANABOLIC STEROIDS
`
`outside the United States (International)
`
`DEA Controlled Anabolic Steroids
`
`Androstenediol
`
`19~Nortestosterone 17—Decanoate
`
`Androstenedione
`
`1 9—Nortestosterone 17—Dipropionate
`
`50t~Dihyclrotestosterone
`
`Fluoxymesterone
`
`Mesterolone
`
`Mesterone
`
`Methandriol
`
`Methandriol Dipropionate
`
`Stanozolol
`
`Testosterone
`
`Testosterone Acetate
`
`Testosterone Benzoate
`
`Testosterone Cypionate
`
`Testosterone Enanthate
`
`19-Nortestosterone
`
`Testosterone 17 3- Hem i succ i mate
`
`I 1-:
`
`Testosterone Propionate
`
`Time Release Pellets Always On Time
`
`Astraleneca Ex. 2044 p. I0
`
`

`
`VIA
`
`T-A
`
`See pages 73-80 regarding
`Hormone/Anti—H0rmone products
`for Immune-Deficient Mice
`
`and specific references.
`
`Your RC-SCEl1‘C]'] Time. Is Under Your Control
`
`Astrazeneca Ex. 2044 p.
`
`I
`
`I
`
`

`
`

`
`

`
`

`
`

`
`(continued)
`
`
`FATTY ACIDS
`
` .
`
`
`
`."%_-.-
`
`Use Time To Your Advantage
`
`AstraZeneca Ex. 2044 p. I6
`
`

`
`(continued)
`
`Consistent Results With Consistent Release
`
`Astrazeneca Ex. 2044 p. I?
`
`

`
`F
`ADVANTAGES OF OUR MDD PELLET SYSTEM | A
`
`. Saves time
`
`9 Ready-to-implant
`
`.
`
`lnsures controlled product release over time
`
`. Avoids “peak and valley” effects
`
`9 Guarantees consistent product preparation
`
`o Extends product life against spontaneous breakdown
`
`. Extends product life against host-related breakdown
`
`9 Minimizes experimental variables
`
`4»
`
`lnsures safety of the researcher
`
`. Reduces neurophysiological trauma to the animal!
`
`no "cessive handling
`
`o Generates more meaningful and reproducible results
`
`o Superior to conventional delivery methods
`
`0 Enhances experimental efficiency
`
`o Frees valuable time for creative research
`
`0 Saves money
`
`Time.-Release _Pe.llets... Alw'ays On Time.
`
`Astrazeneca Ex. 2044 p. I8
`
`

`
`
` PLACEBO / CONTROL
`PELLETS
`
`
`
`Matching Placebo pellets contain all the components of the hormone or drug pellet except the active
`product itself. The carrier-binder excepients of the matrix include Cholesterol, Lactose, Celluloses,
`Phosphates and Stearates.
`
`Although the matrixes in Placebo pellets have a different composition for different active products,
`
`Stock Placebo pellets are available in 20 different doses corresponding to those of active product
`pellets. Each dose is offered in either 21 Day, 60 Day, or 90 Day Release form.
`
`theyareallassignedthesamecatalognumberandareofferedatthesamepriceschedule.
`
`When inquiring or placing an order, please specify the active product you wish to correspond the
`Placebo pellets for. Please see the following examples:
`
`
`
`
`
`I
`
`'
`
`I
`
`II
`
`iI
`
`II
`
`I
`
`u_
`
`I
`I
`'
`
`
`
`
`Description
`
`Dose in Ingfpcllet
`
`Release in Days
`
`Placebo for “Active Product" j mg/pellet
`
`Placebo for “Active Product”*
`
`mg/pellet
`
`Placebo for “Active Product“
`
`__ mg/pellet
`
`21 Day
`
`60 Day
`
`90 Day
`
`*In place of “Active Product” specify the hormone or drug you are utilizing in your study.
`
`The following three pages are universal dose fprice schedules in all three release rates (21 Day, 60
`Day, and 90 Day) and are applicable as a matching Placebo for all products in the catalog except
`special physical size and preparations (page 94) which can be found under the Custom Pellet section
`on pages 93-108.
`
` *Please inquire directly with us 9"further assistance is required regarding a product ofinterest
`
`Astraleneca Ex. 2044 p. 19
`
`

`
`
`
`M
`
`Astrazeneca Ex. 2044 p. 20
`
`

`
`
`
`1..
`
`0.01 0
`
`0.025
`
`0.05
`
`0.1
`
`0.25
`
`0.5
`
`1.5
`
`2.5
`
`5.0
`
`$697
`
`$697
`
`$697
`
`$697
`
`$697
`
`$697
`
`$697
`
`$697
`
`$697
`
`$702
`
`$1 362
`
`$1362
`
`$1362
`
`$1362
`
`$1362
`
`$1362
`
`$1362
`
`$1362
`
`$1362
`
`$1379
`
`$2649
`
`$2649
`
`$2649
`
`$2649
`
`$2649
`
`$2649
`
`$2649
`
`$2649
`
`$2649
`
`$2674
`
`$481 6
`
`$4816
`
`$4816
`
`$4816
`
`$4816
`
`$4816
`
`$4816
`
`$4816
`
`$4816
`
`$4858
`
`7.5
`
`10.0
`
`15.0
`
`25.0
`
`35.0
`
`50.0
`
`75.0
`
`100.0
`
`150.0
`
`200.0
`
`$702
`
`$702
`
`$707
`
`$707
`
`$707
`
`$707
`
`$718
`
`$718
`
`$723
`
`$1379
`
`$1379
`
`$1 386
`
`$1386
`
`$1386
`
`$1386
`
`$1406
`
`$1406
`
`$1415
`
`$2674
`
`$2674
`
`$2674
`
`$2674
`
`$2674
`
`$2674
`
`$2734
`
`$2734
`
`$2744
`
`$4858
`
`$4858
`
`$4875
`
`$4875
`
`$4875
`
`$4875
`
`$4945
`
`$4945
`
`$4964
`
`A combination of multiple dosages in one lot, for any specified product, is also
`available. PLEASE INQUIRE.
`
`Sixty and Ninety day price schedules are on the following two pages.
`
`
`
`Astrazeneca Ex. 2044 p. 21
`
`

`
`
`
`
`
`PLACEBO PELLETS
`
`PRICE SCHEDULE
`
`Cat. No. SC-1 11
`
`A combination of multiple dosages in one lot, for any specified product, is also
`available. PLEASE INQUIRE.
`
`
`
`Astrazeneca Ex. 2044 p. 22
`
`

`
`fl
`
`_
`
`_
`
`.-.‘
`L.4_'._.
`_
`
`' "
`"'
`'-
`'-
`_,
`:
`'
`.'
`._._.
`I.__.__.._____.I_._.:. ._ _ —_——_. — —.7._~_—-
`
`'
`'
`.—.--,u. -=;»-,—,_—-.-_—.
`
`—
`
`pu-r
`
`~
`
`EELLET
`
`.
`'
`
`.
`
`.~.--
`'.
`'-
`'.
`':
`-_ .
`-
`.-
`.-
`:'..
`-
`'
`.-5 ._ -.-.~
`.
`-
`-
`-
`..'.._.'.._-..._..._._ '_.'_..-_a .._._ _.'. .._...'_.«.
`._.,..-I_.-1-_w:»|_-..-..-.,.,......._...—.—,.—.. .—,—_—-_.,_._—_._—..—....__.. =- —i
`
`_..— _...£
`
`PRICE SCHEDULE
`
`H’: E‘:
`:‘r.', "J?"
`
`._a F ,._.I1'. '- .‘ _.
`
`.
`
`Cat. No. NC-111
`1|:'r§;.‘.'-"'
`-.*"-
`
`A combination of multiple dosages in one lot, for any specified product, is also
`available. PLEASE INQUIRE.
`
`
`
`Astrazeneca Ex. 2044 p. 23
`
`

`
`BIOMEDICAL RESEARCH IN LABORATORY ANIMALS
`
`TIME RELEASE PELLETS FOR
`
`._'.l?éj'-iii':C0nti'n'i1.iJus Pain_i1_1 I)RUG
`
`H
`
`H
`
`in
`
`I
`
`_
`
`Release Pellets Arethe Best Alternative
`I
`I
`I
`I
`I
`I
`Time Release Pellets
`for Biomedical Research from IRA
`DOSE
`
`
`
`RELEASE
`
`O)))))))))))))))))))
`
`O))))))))))))))
`Q>>>>>>)>>>)>
`
`
`Tl.-VIE
`
`
`
`Our Team at IRA is working
`
`to meet the responsibility that
`
`Innovative Science demands
`
`and Innovative Scientists
`
`deserve.
`
`i
`
`$4»
`
`'2".--———-
`
`Astraleneca Ex. 2044 p. 24
`
`

`
`

`
`Astraleneca Ex. 2044 p. 26
`
`

`
`ALPHABETICAL PRODUCT LISTING
`
`Dose/Price Schedules For Matching Placebo Pellets Appear On Pages 17-19.
`
`21-Day Release
`(_T::l:1lug f’:'iI:u
`!-lc|:edu|L-r'
`.\u1nhe:‘ I’a;.I,L'-. NlI]'I1l}l1'I‘
`
`60—Day Release
`Cntuing l'riu'.
`.‘-iL'he.dule.I'
`i\‘un1hrr Page
`NI.I[‘!llJl.‘I'
`
`90-Day Release
`C2'Il:'I.lIJ$.'. Price SI:!1aduIe!
`Nulnln;-r Pa[.-.I;- Numlauzr
`
`Acebutolol
`
`Acetarsone
`
`Acetopromazine
`
`'N—Aeetyi-L-Cysteine
`
`A
`
`.. _.
`
`.
`
`.
`
`In
`
`
`
`(Daminomycin)
`
`I
`
`Adenosine
`
`l.’._‘.39*-*_i€=IX»“~0eton'e Powder. =
`
`Adrenosterone
`
`C-101
`
`B-165
`
`C-102
`
`0-212
`
`0-2273
`
`K-111
`
`K413
`
`N-111
`
`G-11?
`
`NC-101
`
`B-90!50
`
`.
`
`B-BOMB
`
`E-60:'58
`
`C-60!52
`
`__.'
`
`" "
`
`I
`
`C-90:’53
`
`3-eo:49
`
`3.9050
`
`"I
`
`I
`
`*
`
`0.135
`
`-
`
`a—eo:49
`
`-
`
`A
`
`3.9050
`
`0.111
`
`_.Q-"121
`
`_
`
`'_
`
`B-166
`
`M151
`
`I-111
`
`B—60!49
`
`B-90:'50
`
`_
`
`f:+6:0}S'2_."-=‘
`
`'_
`
`B-60!49
`
`B-90!50
`
`T
`
`I
`
`% Hyeiozefz 7
`
`A‘-10.3 .
`c--431
`
`I .
`
`I
`
`* I f
`0-2154
`
`21
`
`B-some
`
`~ A?!~':::EiO'f4ii6_¥
`Ewaorss
`
`I
`
`-
`
`B-90350
`
`I
`
`0.9055
`
`Astrazeneca Ex. 2044 p. 27
`
`

`
`ALPHABETICAL PRODUCT LISTING
`
`DosefPriee Schedules For Matching Placebo Pellets Appear On Pages 17-19.
`
`21-Day Release
`Ciltillllg l’ri::I.‘
`SL'ItI.*du|I:.v‘
`:\umher Page Number
`
`60-Day Release
`Calallag Price Scln;-(lulu!
`‘1\'umher I’age Nulnher
`
`90-Day Release
`(‘.a|Ial<.Ig Price SL'h|.‘(lll|I‘.'J"
`-.\Eumher Page Nmuller
`
`SA—104
`
`3-90:49
`
`NA-104
`
`9-90x50
`
`SB-167 _ 9-90:49
`90.119
`A-GOI46
`
`.
`
`-so-181
`SA—105
`
`B—60f49
`B-60149
`
`NB-167
`NG-118
`
`ND-1'81
`NA—105
`
`3:-90:50
`A—9DI4?
`
`3-90:50-
`B—90f5{)
`
`.
`
`1
`
`'3 SA-109
`
`A-60;'46
`
`NA-106
`
`A-90x47
`
`Althiazide
`
`Z
`
`-.
`
`.
`
`Air-nei-nonide
`
`H
`
`I
`
`Amlneaclelloelitrilel
`
`H I
`
`"0E?!§&;fiaifi<§§0et0p.h'gqon-g_"
`
`'
`
`_
`
`I
`
`m-Aminoacetophenone
`'52 '_|;:AtiJih0a'ce:t0'phel1one-
`Arrlinogluiethimide
`—. ;9_';§fmi0fiPépi¢i_:;|§nap-Acid _
`Anmiaonphylliae I
`I
`
`_._'
`
`I
`
`'
`
`.
`
`_
`
`I
`
`.
`
`i
`
`I
`
`__
`
`-
`
`_
`
`I 2
`
`1.;
`
`'
`
`_
`
`I
`
`In
`
`I Amliedaro-ne
`
`H
`
`I
`
`I
`
`I
`
`I
`
`I
`
`_g
`
`'
`
`__
`
`'
`
`..
`3,;3,:.j*i~\;:_'.__ __.I
`I
`!E*—!'.|dfUS.t‘.eI'Iedi.C}|'.
`(SeaCon*mltadSubsIanc.asPageB}
`..
`Z
`_ _.:
`
`__
`
`;~}\
`
`._
`
`.
`
`.
`
`'.“Ara0l1i00n.i'c:A0i'0.
`
`I
`
`I
`
`I
`
`_
`
`'
`
`I
`
`22
`
`_
`
`-
`
`SA- 10?
`SA-108
`SG—281
`99-111
`sc-125
`- _sA-109
`SA-112
`
`-sc-451
`se-112
`
`-SB-.113
`SB-1'14
`
`B-60!49
`B-SW49
`D-5{}.’55
`'B—60!49
`C-00:52
`3-90.99
`B-60!49
`
`C-60!52
`B-60!49
`
`NA-1 07
`NA-108
`NG-281
`N9-111
`NC-125
`NA—109
`NA-112
`
`NC-451
`NB-112
`
`B-90:'5{}
`B-QOISO
`D-9(]f56
`9-90x50
`0-9:953
`B—90f5D
`B—90.’50
`
`c-90:53
`B-90!50
`
`NB-113
`D_-60'!.55-
`B-60!49' Ne-114
`
`..D‘f-90:56
`B-90:'50
`
`so-107 -. A-9'oI46_ N0-107' A-9014?.
`SA-131
`B-60.949
`[ISA-131
`B.-90350
`...NA_’.12.1.__
`_. B:_9'D!5O..
`NA-141
`C-90:99
`
`C-60:'52
`
`SA-141
`
`‘S9-:=1_.:01
`9K-114
`
`'-SK’-115
`so-401
`
`b;§0{55
`B-SW49
`
`"NA-101
`NK-114
`
`-Bi90_z49.'
`c-90:52
`
`_ NK-115
`NC-461
`
`0-9005“
`B—90f50
`
`B:-'9_0K50'
`c-90:53
`
`'
`
`--SF-.111
`SF-1.61
`
`A-SW46.
`A-some
`
`NF—111
`NF-161
`
`A—9_0f47
`A-90;’47
`
`Astrazeneca Ex. 2044 p. 28
`
`

`
`ALPHABETICAL PRODUCT LISTING
`
`l)ose!Price Schedules For Matching Placebo Pellets Appear On Pages 17-19.
`
`21-Day Release
`
`60-Day Release
`
`90-Day Release
`
`C::ta|u;_-, Price Sulxednln-.n'
`Number Pa -1: Number
`L
`
`S1:l1I.‘tlu1¢.'f
`Cniaing 1’:-ice
`Nuuniwr l’3'rL'- N1.I:nhI:1'
`I-.
`
`{.'a!:1|()g Price Sum-tiuluf
`\1m:.|.1er P:1'=e
`\'umIJL-r
`la
`
`I‘ D-Aslearagine
`-_.5r§éria9ir'ié.
`W I...-1.-ASpE3.I'!iC Acid
`
`I gspgrin
`
`Ateopine
`'gA__’t’:r’c:'>_r':.i.r'1e MelhyiBrornide
`iii-filalaldenine
`
`}F_.»_J_é§:2ar§ytia‘ene
`5—Azacytosine
`
`- 8.-Azahypoxanthine
`"
`
`.
`
`A
`
`___
`
`__
`
`1.
`
`7
`
`.
`
`_.
`
`__
`
`
`
`%
`
`_
`
`__
`
`.
`
`'
`
`'
`
`-
`
`'
`
`C—6U;'52
`
`%
`
`I
`
`.
`
`'
`
`I
`
`%
`
`—
`
`I"
`
`-
`
`'
`
`._
`
`_
`
`'
`
`%
`
`c%§sfiksé% M
`-C'—60i52_-
`B~50!49
`
`. "
`
`‘_ -' M0145 I"
`C.-6(.)!52 H
`"C-5<.30!5'2__
`C-SW52
`._B—60;‘49__
`
`I
`
`.-
`
`.
`
`_
`
`
`
`_
`
`.
`
`_
`
`B-5U?49
`
`'_
`
`__B_-was
`C-5UJ.'52.
`
`.Be-e60}*49%7 j
`I B-503.49
`
`C-90.-"53
`
`C-90553
`
`%
`
`c—9o;53
`
`I B~9§!5b
`
`I
`
`_A_-9_D!4?
`C-90:'53
`I C.§30!53
`C—9fi!$$
`Seersu-
`
`B-90.350
`
`"
`
`‘
`
`'_B-§o}_éo
`C-é{.J.-".53.
`
`eeB-Qeokso
`B-90.350
`
`Beclomethasone
`
`$éIp'e_.hid'iiIinicAcid.
`
`.
`
`'
`
`'-
`
`-'
`
`.
`
`_
`
`Berberine
`
`23
`
`.
`
`'A_—6_og4_s':-:
`
`'-
`
`': =;;§g'or4?"-
`
`D-SW55
`
`D‘-':f.3a':1.*_5_:53.'
`
`I:
`
`C—6D!52
`
`D-9G;’56
`
`:1 »_E§—'9_fif.S5"
`
`c—9o;53
`
`Astrazeneca Ex. 2044 p. 29
`
`

`
`ALPHABETICAL PRODUCT LISTING
`
`I
`
`Dose/Price Schedules For Matching Placebo Pellets Appear On Pages 17-19.
`
`21-Day Release
`Ca1ai0;1 Price Scllcdulef
`Number Pagl.‘
`.'\5u:12lw.-.r
`
`60-Day Release
`{i:1taII:;'_-, Price Scheduler’
`|\':m1her!’u,-,_.:e Nun1I.m'
`
`90-Day Release
`Cfatalug l’ric.e Schedule!
`.\'um1n:r Page Numher
`
`Betarnethasone
`
`G-191
`
`L-21363
`
`SG-191
`
`L-BOIB4
`
`NG-191
`
`L-90165
`
`'
`
`'l3oId_ine
`
`K420
`
`I C-21.151 .
`
`I
`
`SK-120
`
`C-60a'52
`
`NK—‘l20
`
`C¥90f53
`
`8vBromoadenosine 325' Cyclic Monophosphate
`
`N-221
`
`M-21i66
`
`SN-221
`
`M-60~67
`
`NN—221
`
`M-90:'68
`
`I
`'.Btome_criptihe Mesynlate
`
`I
`
`'
`
`-
`
`C-231
`
`E-21x57
`
`SC—231
`
`E-60!58
`
`= NC»231
`
`E-90359
`
`5-Bromo-2'-Deoxyuridine {emu}
`
`N-231
`
`B-zma
`
`SN-231
`
`B-BOMB
`
`NN-231
`
`B-90:'50
`
`C—21:'51
`
`SK-122
`
`C-6U!52
`
`NK-122
`
`C-90.’53
`
`- Bfucine _'
`
`'
`
`Busulfan (Myieranjl
`
`"C-affefline
`
`Calycanthine
`-_ ti-:afi:p:o_t'h"e__cin_
`
`-
`
`'-
`
`K-122
`
`Z-130
`
`C.-191.
`
`B-21148
`
`SZ-130
`
`B-SW49
`
`NZ— 130
`
`B-90l50
`
`c—21;51 .
`
`sc—191
`
`C-80.r‘52
`
`NC-191
`
`C-QOIS3
`
`
`
`
`
`".'T‘-'-..T‘.r'a-._n-_"-"_-At-—Iu"'—E|74i'17i"'-
`
`K-123
`
`B-21.r‘48
`
`-C-116 -'
`
`cm?
`
`'
`
`_' C-1__13-
`
`E—2_1;'5?
`B-21I'48
`
`"C-21:51
`
`SK-123
`so-115
`SC-117
`
`B-SW49
`
`NK-123
`
`B-90260
`
`E-60158
`
`NC-116
`
`E-90.59 .
`
`B-60!49
`
`NC-117
`
`B~90;‘50
`
`_‘.I;.':.._'nILn..|n.n_.:_.
`
`30-113
`
`C-SW52
`
`NC-113
`
`C-90!53
`
`C-4?1
`
`c-21:51
`
`SC-471
`
`C-60x52
`
`NC~471
`
`Captopril
`I
`I
`'_:_:3 ‘.'CaIrbamazepine
`Carbinoxarnine
`
`_'b[:;§.Ca'rnitffie
`
`I3-Carotene
`
`I
`
`I
`
`‘V5271
`
`‘<3-21:51
`
`SV-271
`
`c—6or5_2
`
`N'V¢27‘i
`
`V«215
`
`C~21:’51
`
`SV-215
`
`G60! 52
`
`NV~215
`
`C-90f53
`
`090153
`
`c-90:53
`
`:
`
`!-__
`
`'
`
`I
`_-'-7G}a"sbdex:ifii'c$iut§_r§ai}ié')
`
`5
`
`‘
`
`'-
`
`I "
`
`"We ca}:-i:'us.t¢:i:_i'1.'make
`
`dose and any reiease time. (PLEASE INQUIRE) _.
`
`Cefadroxii
`
`'.':'-_-Cefarrjand_Q_lé""f'
`Cefazolin
`
`_
`
`_
`
`B-170
`
`A-21:’45
`
`SB-W0
`
`A-60!46
`
`NB-170
`
`A-90;'47
`
`'
`
`.'si171'- - A-21:45
`3-172
`A-21145
`
`SB-1?1
`SB-1?2
`
`_
`
`.....E_W_3..
`
`=.'A;2_1;4s'-__
`
`gs.-173 '_
`
`.
`
`A—6o}46
`
`I NB—1?-1
`
`A-90:4?
`
`I
`NB-172
`
`‘NB-1 73 -
`
`A-603116
`A-60:'46
`
`A-90347
`-A'.9fik4? '
`
`A-21!-45
`_ A-21145
`A-21!45.
`
`33-174
`
`A-SOME
`
`NB-174
`
`A-QOJ4?
`
`53;-175 '
`
`A.-SW46
`
`15439175
`
`' A_-.90r47 -'
`
`53.175
`
`A-SW46
`
`NB-176
`
`A-QOI4?
`
`__'A'-21'r45
`
`53.177
`
`A.-SW46" _
`
`A-21!45
`
`ss-17s
`
`A-SW46
`
`NB-1?"?
`NB-1?8
`
`3-174
`
`" _-s-'1f5
`
`B-176
`
`'- 3-177
`
`B.-178
`
`'-A+9o!47-"
`
`A-90:4?
`
`C"-90153
`
`B-90:50
`
`Cefoperazone
`H
`I
`I
`esesssscieféitaksimé
`Cefoxitin
`
`"
`
`'.C}éféuIédin’.
`
`Ceftriaxone
`
`'
`
`1
`
`'_Centrephen_q>_:ine (Me¢I'ore'nox'a:é)
`
`Cephalexin
`
`(3.115 _
`
`C-21l51
`
`sc-115
`
`C-S0352
`
`NC~115
`
`B-118
`
`B-21!48
`
`ss—11 3
`
`B-60!49
`
`NB~118
`
`24
`
`Astrazeneca Ex. 2044 p. 30
`
`

`
`ALPHABETICAL PRODUCT LISTING
`
`D0se!Price Schedules For Matching Placebo Pellets Appear 011 Pages 17-19.
`
`.
`Pr0dllCt
`
`21-Day Release
`
`60-Day Release
`
`90-Day Release
`
`(‘;I.la]0g Price Sclwdulef
`NuI1l|)l.’l'I’él{.’,L'
`_\umher
`
`Calnlujz Price Schedule!
`|\‘umin-r I-‘age Numbl.-.r
`
`Catalug Price 5::hed:IlI.-K‘
`Nurnbcr Page Number
`
`B-119
`
`D-21.354
`
`SB-119
`
`D-60!55
`
`lchloramphenicol
`fiarhehehicol Base .
`I Chlorcyclizine
`;%'§{1lbrmedinehe Acetante '
`
`Chloroquine
`
`I ::fie‘.;_ifn:iifiro't}1iazide
`
`Chlorotrianisene
`
`gifihlorpheeiramine
`Chlorprqmazine
`ffzniortnalidone
`Chlorzoxazone
`
`§:§i_metidine
`Cinchonidine
`
`Vginarizine
`
`Clemastine
`
`-
`
`Clenbuteroi
`
`;
`
`Clomiphene Citrate
`{§mip'ramine
`
`Clonidine
`
`_
`
`Clotlrimazole
`
`I
`
`I
`
`I
`
`-
`
`. B—.60!49."
`c—5ox52
`
`'
`
`'
`
`- 04:30:52 5:
`
`'
`
`B-SW49
`
`.0-5052 _ 7
`
`H-60;’61
`
`"C-60i5_2 --
`B-60;'49
`C-_60!5:2 :
`
`B-60;‘4Q
`
`3;6or49 _'
`B—B0!49
`
`I
`
`'
`
`=
`
`I
`
`'
`
`' 2
`
`.
`
`.
`
`'_
`
`'
`
`"
`
`" '
`
`'-
`
`'_
`
`I
`
`-
`
`-
`
`—
`
`-
`
`_
`
`.-
`
`'
`
`_
`
`25
`
`Astrazeneca Ex. 2044 p. 3 I
`
`

`
`ALPHABETICAL PRODUCT LISTING
`
`60-Day Release
`
`90-Day Release
`
`{_‘aI:':lo,r__-, Price .‘-it-l1cdu|ea'
`Number Page
`.'\iurr1heI‘
`
`C:I.t:t|ug Price .‘5«':i1uduluf
`Nunxlrer P:-.u':,e Numlmer
`
`
`
`21-Day Release
`Cat:-flog Price biehudtllef
`i\'un1In:rPage
`I\'Lm1l,H.'r
`
`
`
`
`
`
`
`
`
`Product.
`
`Cloxacillin
`
`Cortexolone
`
`
`
`e-some
`
`B-90!5O
`
`
`sB-127
`
`1
`
`
`
`
`NG-301
`ING"-311
`
`B-90;'50-
`_-B-9'0r5o'-_=_:f
`
`
`
`se-301
`-so-311
`
`se-111
`
`B-some
`B-6.0349
`A—B0f46
`
`
`
`
`
`
`s+<-124
`SC.—11 2
`
`so-195
`
`
`A-QOI4?
`A—60f46
`C-90153
`C-5U352
`
`B—6Uf49
`B-90i50
`
`
`
`
`fie-1-71
`A-.9'0i47 '
`
`NG-121
`
`B—90!50
`
`A-QOI4?
`
`- =36-171'
`
`-_A_-6{J:'46
`
`se-121
`
`3-some
`
`_ _sG-131
`
`
`B-60!49'
`B—90f50
`
`
`sk-125
`D-5Uf55
`D-90f56
`so-103
`A-SW46
`A-90.’-47
`
`
`sz- 150
`A-60146
`A-QOF47
`
`53- 123
`B-Ei0:‘49
`B-90.550
`
`
`so-332
`D-60!55
`D-90a'5fi
`
`so-431
`A-BOMB
`A-QOI47
`
`
`so-114
`E-60f58
`NC-114
`E-90:59
`
`
`C-90f53
`SQ-201
`C-60f52
`C-60x52 -HNQ-211
`c-30:53
`so-211
`
`
`NQ—221
`D-90f56
`30-221
`0-60:55
`
`
`"so-23-1
`043052
`C-90I53
`
`
`SZ- 160
`D—60!55
`D-SW56
`
`‘SK-126
`E-60!58
`E~9l3‘!59
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`c-90x53
`
`D.-9Ui56
`
`SN-241
`
`02:30:52
`
`SZ- 1T0
`
`H-60161
`
`H-90182
`
`26
`
`-I
`
`Astrazeneca Ex. 2044 p. 32
`
`Coflicosterone
`
`-}a;c':'da'i_e':t'e-'
`
`Cortisone
`
`5 _.c'_"c»ar'_t_'s-»;:a"21"-¢_;='_' Aeété'te.'
`
`_
`
`(-)C0tinine
`I:in , _.Benzopyrone]'
`
`Cromoiyn
`
`'
`
`-.__C_r(3t_aIine_
`Cjclizine
`'cyc:'op'hogphan1ide (omen:
`D.-Cycloserine
`I
`'."--zzymarin
`_
`_
`Cyprolheptadine
`_cypr:q£e_;o:n'_e'.3x:cetate
`D-Cysteine
`I
`
`.
`
`3
`
`'
`
`3
`
`['3-cystifie
`
`Cytarabine {cytosine Arabinoside}
`-. c—i-y_1fisi_n_,e-._'__:-
`I
`'
`
`Cytosine
`
`
`
`Daunorubucine
`
`
`
`
`
`-Dana_zc_:l
`
`._
`
`'
`
`SP—251
`
`D-50x55
`
`

`
`ALPHABETICAL PRODUCT LISTING
`
`D0sefPrice Schedules For Matching Placebo Pellets Appear On Pages 17-19.
`
`21-Day Release
`L‘.:1tateg Price éiultudulci
`_\"umt:L-I‘
`!"a;ge
`NI:m[.1L-I‘
`
`60-Day Release
`{.‘.:tta!ug 1"ri(‘L- Schcdu1e.»’
`Number Page Nm!1hI:r
`
`90-Day Release
`
`Catalog I‘:'iu- Eict1I:du1e!
`.‘£1|tntu;-r'I’t:§.r,e
`.\‘umbe:'
`
`3-Deazauracil
`
`SN-251
`
`B-SW49
`
`NN-251
`
`B-90:'50
`
`'
`"'
`'_¢_»;_i¢i_':__au_i:¢1‘ine'-
`I-Decamethonium Bromide
`I
`
`'.9:¢.5Tri$$cami.ne‘:?V!é$»?i'aite
`- -‘I-.Dehydrocho|esteroI
` ‘F.;,§jd;¢:¢_:-idlipg Acid.
`
`"f-_ -
`
`__
`
`1-
`
`I
`
`'
`
`'
`
`'
`
`Dehydroepiandrosterone [DHEA)
`l§éti;rdreepiandreslero'fie Acetate .
`
`
`I
`
`Dehydroepiandrosterone Sulfate
`
`Z i6'-Dehydrop_reg'ne'no|one
`
`16-Dehydropregnenolone Acetate
`1:-_,1.tfi-:'!;)e_hydroprogesterone
`
`Demeclocycline
`J
`.433.‘ ;
`j-'[_'=;'.'__DeexychoIic Acid
`
`Deoxycorlicoslerone (DOC)
`5§__':'f_§.‘_fieexyeorticosterone Acetate (DDCA)
`
`Desipramine
`
` :,:.F-* "' [jesoximetasone
`
`Dexamethasone
`
`D_exam_ethasone 21-Acetate
`
`Dexamethasone 21-Phosphate
`3%--Diayeridine
`N5-O2-Dibutyryladenosine-
`_3f:5'-.C_y_cIic M_onophosphat_e
`Diiciofenac
`
`Dicloxacillin
`
`SE;-":Dier1"est'rc:I
`
`.
`
`Dienestrol Diacelate
`
`B-B0.-'49
`
`D-SW55
`
`B-80f49
`
`B-60a'49
`
`-
`
`'
`
`.C'-_60:5:2 '
`
`B-60:'49
`
`_A.'5ox46-
`
`_
`
`B-60!'49
`
`D-60!‘ 55
`
`D':e0_t5§
`
`.'
`
`' I" "
`
`D-60355
`
`L-60.-'64
`
`_eJs0;49.'." =
`
`B-60!49
`
`C"-s.0'152 " I
`
`I
`
`"I
`
`ssi°B7-éo?5b“A
`B-90:'50
`
`B.-9CII50. I
`
`sfeéisaémk
`B-'t~}0i5{}..
`
`-. :p;9o;_5_e__:
`I3-$0.358.
`* 7’” D+90}'Se}
`
`D-90155
`
`"_:_J_§90:_5s3_'
`L-90:'55
`
`A
`
`"
`
`'
`
`Z
`
`
`
` } We
`
`B-QOISU
`
`C-60r'52
`
`C-90:'53
`
`Astrazeneca Ex. 2044 p. 33
`
`I I -
`
`rase
`
`use
`
`ik4_7_f_'
`
`use
`
`

`
`ALPHABETICAL PRODUCT LISTING
`
`I
`
`21-Day Release
`(.‘uI-.3I<1gl-’:'icI:
`§icl1L'tlu|e.u'
`E\'u:nber Page
`.\'um[.n.-r
`
`60-Day Release
`(..‘:11aIu;._: Price Sclietlulef
`I\'un1herl':a;;-,3 Number
`
`90-Day Release
`(_‘.aI;:|ng Price .‘iL:lt(-d:I|u.r‘
`E\'11mIJer
`I‘:-Ige
`.\'un1l1L'-.r
`
`Diethylstilbestroimes}
`
`E-151
`
`B~21:'48
`
`SE-151
`
`B-60:’49
`
`NE-151
`
`B-90350
`
`C-2&1
`
`;_::-5+-'9:g_r.5Q.=::';
`3-92-1314-31".‘.-_ ."_E$g.-.1i93_ -' -_.3-'_60_z49= 2- mg-‘-19;6
`.3-90150.“.
`I 321143. 30-271 “'3-30149.
`NC-2:11."
`_
`_
`_E-2-115.7.-_-'
`'.3K_-'-.127'-
`'_:E-30153
`1\_I_r_<-_-12_:r_;'._ E;§0__r_5§.'_”=
`lspe-eial Dosinlgnlfl-'1')r |m3u1no~Deficient Mice.'See pages ?8-80
`
`1
`
`'
`‘
`
`_
`A-90147. 2;
`D-90."5B
`
`A_.—.2-_1:’4_5
`D-21.*'54
`
`3'-_21_;43
`3-21:43
`
`C-'2__1_r51=
`A—21:'45
`
`-SA-.‘_I_61_ ._ A-_60!46 _ -M-131
`SD-‘I06
`D-60!55
`ND-106
`
`’_sT- 231
`ST- 241
`
`5020;
`so-117
`
`3-33149
`3-30.30
`
`0-30.52
`A-30:43
`
`NT- 231
`NT» 241
`
`‘NC-205
`ND—11?
`
`390150
`3-90150
`
`C-90:’53
`A-90!-4?
`
`.
`
`if
`I
`I
`I
`-53¢-ll-I)ihydroIestoste.r0r1.e'A
`H
`_
`_
`I
`I
`__
`._
`_
`{Se-eControIIedS:_:i}s:a11ce5PageB)
`_ __
`'
`1..;"_:.-__5;g;;3i:hyqyg1g§1_g_s1ero:n-e;
`.
`'
`" -Iseéiootwdbd S.»uIbs=an.=es Pasaai '1
`SIB-Dihylrdrotestosterone
`
`I
`
`7E‘j-$.;j5§Pi'iO§i3‘fE5L§Irijfronifle..
`3;5-biiddid-L-Thyronxfine
`
`1
`
`.
`_
`1
`‘If-._iiE--Iji_tp§:§1hydfi_h3g§,.
`I
`9,1'(}-Di11'.1e'tI1yI-'192-Benzanthracene
`
`__
`
`I
`
`_
`
`-.
`
`_
`
`;.'
`
`-
`
`I
`
`_
`
`- 3-1.31 '
`D-106
`
`I "j-T-2'31"
`T—241
`
`'
`
`__
`
`:_ C-205
`0-117
`
`_. -_-o-101
`
`3-21:43-_
`
`so-101
`
`B-60!_49
`
`ND—101
`
`3-90:50
`
`c-21151
`3-21143
`c-21:51
`
`313-102
`so-500
`so-109
`
`06052
`3-30:49
`C-SW52
`
`ND-102
`NC-500
`ND-109
`
`c-90:53
`3-90:50
`C-90!53
`
`Dipyrone
`".'.'_'_.l'3i_$1.::.;:5'yr:_"a_1__11'icl_:=._-'._'_
`l.3i's.u|fi'rar.n
`
`-
`
`'
`
`'
`
`-
`
`_
`
`_'
`
`3-132
`1;:-"500
`'3-109
`
`__c_:-50_1_
`0-502
`
`_3-21:43
`c-21151
`
`so-501
`so-502
`
`DL-0c}p'a
`
`I
`
`'
`
`5.: ._
`I D3par=:1i11.e.."
`I
`I
`
`I
`
`I'D-33-fieyciine
`
`H
`
`_
`
`lfllrelfleninel
`
`I
`
`.
`-
`in
`
`-.
`
`'_
`
`'. -.
`
`.
`
`Sc-503
`'G~2_1f_51
`(3:-503
`so-151
`c-2.1151
`Tc-151
`so"-32.5
`515;]. 93253 :_B-934800
`I
`I
`3-133
`A-211'45” 33-133
`§_(:_-.50.;
`-_fc-21.151" _'s'c-504
`0-103
`C—21;’51
`so-103
`
`I .1-E)'rep.ropizir1e I
`
`___'_3-:Eg3_yg§ne_..
`'HE.c1033zo|3'
`
`I
`
`:
`
`--
`
`-_j
`
`_
`
`_
`
`13-1_04_
`I D-105
`
`_A-2114-5'
`C-21:51
`
`30”-1'04
`so-105
`
`-
`
`-
`
`-
`
`" .
`
`.
`
`E-103
`3-131
`
`H-21130" SE-103
`3-21:43
`33-131
`
`28
`
`3-30:49
`c-30152
`
`C-60i52
`c-30152
`-BA-W9
`A-60!-46
`0'-60152
`C-60I52
`
`_A—60.’4-S
`C-60:52
`
`H-60:‘61
`3-30:49
`
`NC-501
`NC-502
`
`NC-503
`NC-151
`“@3251
`NB-188
`NC-504
`ND-103
`
`ND—1{}4
`ND-105
`
`NE-103
`NB-181
`
`3-90150
`0-9033
`
`c-9.0153
`c-90.153
`390150
`A-QUI4?
`C-90!53
`C-90!53
`
`A-90:47
`C-90f53
`
`H-90:52
`3-90:50
`
`Astrazeneca Ex. 2044 p. 34
`
`

`
`'r_
`
`ALPHABETICAL PRODUCT LISTING
`
`21-Day Release
`C:lI'.'I1l)g ]"ri(.‘I:
`.‘s'L'l1t*:l.tJ11:!
`.\iumh1;-r Page Number
`
`60-Day Release
`(';1l;1I0;_;I_ pFi(‘.l.‘ Sclledull;-1'
`.\lum|Jer Page Number
`
`90-Day Release
`l.'2!t:Jlu:;: 1'!'}:.‘I.'
`-Schudlilef
`_\'umher Page
`_\'umher
`
`C-122
`
`A—21!45
`
`sc-122
`
`A-50140
`
`NC—122
`
`A-90147
`
`c-999
`
`'A'—2'11*45
`
`sc-999
`
`A—6D1‘46
`
`I
`
`I
`
`A-001217
`
`no-201
`
`I
`
`c-21151 I
`
`so-201
`
`‘C2-00.152.
`
`c-90153
`
`c-141
`
`0-21154
`
`s0-141
`
`D-00155 “N0-1'41 0-90155
`
`-E-231 _
`E~211
`
`'0.:21154-
`0-21154
`
`'.éE._2_3_1
`se-211
`
`_ p-50155
`0-00155
`
`:_1~'1E‘».23\-1
`NE-211
`
`E-221
`v-291
`
`B-130'
`E-101
`
`E-102
`I K-129
`
`'0-21154
`C-21151
`
`..piE-221
`sv-291
`
`_D-00155
`C-60152
`
`- B-2'1143_ $13-1.30
`B-21148 $5 101
`
`B-00149
`B-50149
`
`NV-291
`
`NE"-1'30
`NE-101
`
`c-21151
`B-211‘-48
`
`sE-102' C—60!52_ NE-102
`s1<- 129
`3450149
`NK-129
`
`0-W50 r
`0-90150
`
`'0'-__90'1s6i
`0-90153
`
`B-9'0_1_50
`B-90150
`
`090153
`13-90150
`
`E-131
`
`0-21154. SE-131
`
`D-60155‘
`
`"NE-131
`
`0-90150
`
`Special Dosing For lmrnuno-Deficient Mice. See pages 73-77.
`
`E-121
`
`B-21148
`
`SE-121
`
`-B-60!49
`
`NE-121
`
`'13-90150
`
`E-2371
`
`B-21!4B
`
`SE—2?1
`
`B-60149
`
`NE~271
`
`13-90150
`
`.E-281
`
`13-211437 SE-281
`
`B~60f49.
`
`‘NE-2'81
`
`13-90150
`
`I2»-Estradiol 1?-Cypionate
`
`E-291
`
`13-21140
`
`SE-291
`
`B-60149
`
`NE-291
`
`B-90150
`
`i;-;,!§?Eslradio| Diacetate
`
`B-Estradioloipropionale
`
`-3 _stradioI 3-Methyl-Ether
`
`E-301
`
`E-311
`
`E~321
`
`B‘-211‘48
`
`SE—301
`
`13250149
`
`NE-301
`
`B»901'50_
`
`B-211918
`
`SE-311
`
`B-60i49
`
`NE-311
`
`B-90150
`
`B-211‘48
`
`SE-321
`
`B-60149
`
`NE-"321
`
`B-90'1"50
`
`1 YB-Estradiol+Pr0gesterone (See Page 391
`J
`‘.‘-.‘'IF'
`:3__'.=__'1'_.°_-E-'_r'-:"§'1'r.'fi:1c1ic:.'1 Propiofiate
`.
`-
`B~EstradioI1?-Valerate
`
`'
`
`" =E-3?-1
`E-203
`
`'0.-21154’
`B-21148
`
`'
`
`D-00155" '.
`B-60149
`
`29
`
`Astrazeneca Ex. 2044 p. 35
`
`

`
`ALPHABETICAL PRODUCT LISTING
`
`DosefPrice Schedules For Matching Placebo Pellets Appear 011 Pages 17-19.
`
`21-Day Release
`L':tI:¢'lI.'Jg I’:-ice Sclnctlulc-I"
`NIm1heI‘l-‘ag-;-
`T\‘un1!u:r
`
`60-Day Release
`C:1t:1i0:_=,
`I’riL'.e Sclu-dult-I
`|\'1|rnher Page Number
`
`90-Day Release
`Catalog Price SL'hi_‘{I'l|ll.’."
`EVum|m'
`i’:1_::e Nunzlmr
`
`.
`
`Estriol
`
`x
`
`.fiétéit-Fe3+E¥ehiI¥|_LeELfEAé¥
`Estriol Triacetate
`I
`":.Estio'=5‘e"'._""1 =
`
`Estrone Acetate
`
`-. "E-.e',_t}one-H'er;1§s1;c¢:ifiate
`
`Estrone 3~Methy| Ether
`_'Es£rcne:g.3QIfate."
`'_
`
`Ethacrynic Acid
`-Ethambutcfi
`Emasterone
`
`I
`
`I
`
`_
`
`-
`
`-'
`
`._
`
`;
`
`_
`
`'
`
`'
`
`*
`
`_
`
`‘
`
`-
`
`.
`
`'
`
`"
`
`-
`
`;
`
`"
`
`'
`
`'
`
`'
`
`-_
`
`I
`
`_
`
`is
`
`B-SW49
`
`D+6L0I55f
`A-60!-46
`Ens-60x49
`
`B-60!49
`
`_
`
`‘D-eorss
`
`-
`
`I
`
`B-60!49
`A-60146
`
`c—so;52
`c—sor52'
`B-some
`
`B-SW49
`
`B-90:’50
`
`A
`
`' D-s9Lorss:
`A-90!47
`B~'90I50'
`
`B-90350
`
`0.9056-
`
`B-QOISO
`A—90I47
`
`c-90:53
`c-90:53.
`B—9U!5D
`
`B-90x50
`
`"'17:;-Eth'y_nyIest}adi§:
`
`Eucatropine
`"
`I
`'FliIdrb¢DrI'i'99'fl_€:
`Fludrocortisone Acetate
`
`-...:FIu'f§'n'émi§_'-Adia.-.
`I
`l'='|Lt'mequ.inr-3
`':-_--'F'1§methé-§_§5e-:
`'FIu'narizine
`
`I
`
`-_
`
`._
`
`I
`
`I
`
`Fluocinolone
`
`.
`
`.
`
`'
`
`'
`
`-'
`
`;
`
`_-
`
`:2?
`
`_'i
`
`I"
`.
`_'
`.-;S:_'jF:;3u‘c_}:oL1j'r?a'£§i:
`FIuoxymesteronle [See Controlled.Subslaraees Page 3;
`."~",,F_F..L!':Jh1e.-ri%‘>:i‘ra’»_a-3.--_._":’_“.- 2 I"
`_ Flurbiprefen
`.--ufizutaniidé:-'_.
`Folic Acid
`
`_
`
`..
`
`-
`
`-
`
`—
`
`I
`
`.
`
`'
`
`I
`
`I
`
`.
`
`=
`
`I
`
`-_
`
`-
`
`Z_-
`
`'
`
`.
`
`'
`
`_
`
`'
`
`D-60;'55
`-B-some‘
`B-60!49
`
`'c-60:524.‘
`C-80:62
`I-.-60x64"
`C~6DI52
`
`‘D-'s0i'5_5-'_
`
`-
`
`'
`
`D-6Ui55
`
`'
`
`- B-60!49
`A-60f46
`cf-60x52
`B-60:'49
`B-60i49
`C-60!52
`
`'
`
`-
`
`.
`
`_
`
`D~90f56
`B-902'50
`B«90!50
`
`-c-:—9o:53
`C-90!53
`-L‘-9I}_.-’65'
`C-90!53
`
`D-9o'r5s_'
`
`D-90!56
`
`.B_-9ox_50_
`A-QOI4?’
`C-QOI53
`B-90:’50
`B-9'Of50
`c-90:53
`
`Astrazeneca Ex. 2044 p. 36
`
`

`
`I?‘
`
`ALPHABETICAL PRODUCT LISTING
`
`D0se;’Price Schedules For Matching Placebo Pellets Appear On Pages 17-19.
`
`21-Day Release
`
`60-Day Release
`
`90-Day Release
`
`Casalug PriL:L-
`Numl_u.'r
`l’:1;:I.'
`
`Scht-(1111;-I
`T\‘u1uht:r
`
`(__‘al:aII_s;g Pr'IL't- ScI1L-chm-I
`Mnminer l’zIge Numher
`
`Cataicu.-, I-'I'ice ti-:im_1LIIL-e’
`Number Page
`.\'|:mhL-I‘
`
`NV-311
`
`D-90!56
`
`‘ D-GlutamicAcid
`
`""é'I'ut:amic'Acid
`
`_‘
`
`_
`
`_
`
`Glutathione (Oxidized)
`:"""’§‘si:ut'ath:one{Remedy
`
`_-._Iy*eine
`Gossypoi Acetate
`
`I
`
`_
`
`_
`Guaifenesin
`
`3-6049
`
`' *
`
`,'_'3i5£dx$S*i _ j:
`c—5or52
`
`e-96:50
`
`if.
`I ‘C-90:55..
`
`'
`
`'- A4'_et1}r45__j_' 1
`D-60!55
`D-90:56
`
`I
`
`'_
`
`_
`
`"
`
`-' ceorsz
`
`-
`
`.
`
`_
`
`D-6055
`
`C-60f52
`
`B—60f49
`c-50:52
`c-50:52
`
`C—60:’52
`D-SW55
`A-SW46
`
`c-50:52
`
`B-SW49
`c-50:52
`
`N-sane
`
`c—eor52
`
`c—so:5